Follow-up imaging reveals that certain biomarkers predict early outcomes in stroke patients, indicating their potential clinical relevance.
NFS on posttreatment MRI is a robust imaging biomarker of persistent perfusion deficits and early neurologic outcome, even after successful reperfusion. SBS may reflect complementary collateral dynamics but showed limited independent prognostic utility.
No takes yet. Share an insight, caveat, or question.
Greene et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: